A key observation highlighted the differences between non-malignant and tumor-derived lung endothelial cells, revealing that Myc targets were the most enriched signature in tumor endothelial cells due to elevated transcription rates, while the most significantly downregulated pathway was associated with inflammatory responses. This evidence concerns the gene MYC and neoplasm.